Evidence map›Paper›PMID 30590505›Full record

ArticleBiostatistics (Oxford, England)2020

Bayesian inference of networks across multiple sample groups and data types.

Elin Shaddox, Christine B Peterson, Francesco C Stingo, Nicola A Hanania, Charmion Cruickshank-Quinn, Katerina Kechris, Russell Bowler, Marina Vannucci

Abstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Bayesian graphical models for modern biological applications.Statistical methods & applications · 2022
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elin ShaddoxDepartment of Statistics, Rice University, Houston, TX, USA.
Christine B PetersonDepartment of Biostatistics, UT MD Anderson Cancer Center, Houston, TX, USA.
Francesco C StingoDepartment of Statistics, Computer Science, Applications "G. Parenti", University of Florence, Florence, Italy.
Nicola A HananiaDepartment of Medicine-Pulmonary, Baylor College of Medicine, Houston, TX, USA.
Charmion Cruickshank-QuinnDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Colorado, Denver, CO, USA.
Katerina KechrisDepartment of Biostatistics and Informatics, Colorado SPH, University of Colorado, Denver, CO, USA.
Russell BowlerDepartment of Medicine, National Jewish Health, Denver, CO, USA.
Marina VannucciDepartment of Statistics, Rice University, Houston, TX, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
TRAINING PROGRAM IN COMPUTATIONAL BIOLOGY AND MEDICINET15LM007093 · NLM · RICE UNIVERSITY · PI Lydia E. Kavraki · 1992 to 2026
$20.8M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Metabolic profiles of COPD phenotypesP20HL113445 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2012 to 2016
$4.7M
NCI NIH HHS P30 CA016672NHLBI NIH HHS P20 HL113445NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NLM NIH HHS T15 LM007093
6 · The paper itself

Abstract

In this article, we develop a graphical modeling framework for the inference of networks across multiple sample groups and data types. In medical studies, this setting arises whenever a set of subjects, which may be heterogeneous due to differing disease stage or subtype, is profiled across multiple platforms, such as metabolomics, proteomics, or transcriptomics data. Our proposed Bayesian hierarchical model first links the network structures within each platform using a Markov random field prior to relate edge selection across sample groups, and then links the network similarity parameters across platforms. This enables joint estimation in a flexible manner, as we make no assumptions on the directionality of influence across the data types or the extent of network similarity across the sample groups and platforms. In addition, our model formulation allows the number of variables and number of subjects to differ across the data types, and only requires that we have data for the same set of groups. We illustrate the proposed approach through both simulation studies and an application to gene expression levels and metabolite abundances on subjects with varying severity levels of chronic obstructive pulmonary disease. Bayesian inference; Chronic obstructive pulmonary disease (COPD); Data integration; Gaussian graphical model; Markov random field prior; Spike and slab prior.

Indexed as

Data Interpretation, StatisticalModels, StatisticalBayes TheoremBiomedical ResearchBiostatisticsComputer SimulationDatasets as TopicGene ExpressionHumansMarkov ChainsMetabolomePulmonary Disease, Chronic ObstructiveSeverity of Illness IndexBayesian inferenceChronic obstructive pulmonary disease (COPD)Data integrationGaussian graphical modelMarkov random field priorSpike and slab prior

Identifiers

PMID30590505
PMCPMC7672535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.